Russia to Launch Ragweed Allergy Vaccine Soon
Russia is developing a new vaccine against ragweed allergy, following the recent registration of a vaccine for birch pollen allergy. The Federal Medical-Biological Agency (FMBA) announced several other vaccines in development, including those for meningococcal infection, dengue fever, and personalized cancer therapies.
Consensus
- A vaccine against birch pollen allergy has been registered in Russia recently.
- A vaccine against ragweed allergy is in development and nearing market release.
- The Federal Medical-Biological Agency (FMBA) is leading the development of new vaccines.
- Other vaccines in development include those for meningococcal infection and dengue fever.
- Personalized cancer vaccines are also being developed.
- The III International Forum 'Bioprom' is taking place in Gelendzhik, October 5–6.
- The FMBA head, Veronika Skvortsova, spoke about these developments at the forum.
Points of divergence
- The birch pollen allergy vaccine was developed jointly by the FMBA and the Vienna Medical University and was first announced in 2021. — kommersant
- The birch pollen allergy vaccine also covers cross-reactive food allergy. — vesti
- The birch pollen vaccine is planned to be administered to up to 60,000 patients before the next pollen season. — kommersant
- Work is currently underway on a drug for glioblastoma. — vesti
Coverage (2 sources)
- In Russia, soon a vaccine against allergy to ambrosia will appear — Коммерсантъ
- Head of FMBA spoke about new Russian vaccines — Вести